Recce breathes better on positive lung infection drug pilot test results
Recce Pharmaceuticals Ltd has revealed positive results from its pilot test on synthetic drug Recce 327, which aims to treat lung infections.
No News & Media currently available.
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.005(2.63%) |
Mkt cap ! $16.20M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.5¢ | 18.0¢ | $60.93K | 327.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 23583 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 169185 | 2 |
View Market Depth
| Last trade - 15.54pm 09/05/2024 (20 minute delay) ? |
|
|||||
|
Last
18.0¢ |
Change
0.005 ( 5.26 %) |
||||
| Open | High | Low | Volume | ||
| 18.5¢ | 19.0¢ | 18.0¢ | 81300 | ||
| Last updated 14.59pm 09/05/2024 ? | |||||
| GRE (ASX) Chart |
